Dementia

Comparative risks of dementia and Parkinson’s disease with GLP-1 RAs versus other oral glucose-lowering medications in obese patients with type 2 diabetes: a large real-world cohort study

Study Overview This study investigates the comparative risks associated with dementia and Parkinson’s disease in obese individuals suffering from type

Comparative risks of dementia and Parkinson’s disease with GLP-1 RAs versus other oral glucose-lowering medications in obese patients with type 2 diabetes: a large real-world cohort study Read Post »

Rising Comorbid Alzheimer’s and Hypertension Mortality in Older Adults in the United States: Trends and Disparities From a 21-Year CDC WONDER Analysis (1999-2019)

Trends in Comorbidities Over recent decades, the intertwining of Alzheimer’s disease and hypertension has become increasingly evident, particularly within the

Rising Comorbid Alzheimer’s and Hypertension Mortality in Older Adults in the United States: Trends and Disparities From a 21-Year CDC WONDER Analysis (1999-2019) Read Post »

Scroll to Top